Innovative Regulatory Review Practices for Better Efficiencies- The Singapore Experience

Posted on

New Drug Approvals

Republic of Singapore
Republik Singapura  (Malay)
新加坡共和国 (Chinese)
சிங்கப்பூர் குடியரசு (Tamil)
Flag Coat of arms
Motto: 
“Majulah Singapura” (Malay)
“Onward, Singapore”

Innovative Regulatory Review Practices for Better Efficiencies- The Singapore Experience

by

Dr Daniel Tan
Director
Health Products Regulation Group
Health Sciences Authority

read all this at

http://www.who.int/medicines/areas/quality_safety/regulation_legislation/icdra/WH-1_2Dec.pdf

overview

Mission
Background

Regulatory Principles

Evaluation Routes
Data Requirements
Regulatory Process
Application Statistics

Pre-market Evaluation
Depth of evaluation varies following a risk-
& confidence-based approach
Three evaluation routes allowing flexibility
yet ensuring robustness in the registration
system
In-house capabilities complemented by
external experts and advisory committee

Conclusion
Resources are always limited in most regulatory agencies
Adopting a risk based approach to triage drug applications
Titrate the evaluation workload by levaraging on reference agencies
assessment reports
Managing Access to important medicines without prolonging
timelines
For small markets like Singapore, this unique system of drug evaluation,
ensures that market entry of…

View original post 17 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s